A Two-Period Crossover Study to Compare the Systemic Exposure to Trans-Capsaicin and Cis-Capsaicin From an Intra-Articular Injection of CNTX-4975-05 (Trans-capsaicin for Injection) and Topical 8% Capsaicin Patch (Qutenza) in Subjects With Painful Knee Osteoarthritis
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2018
At a glance
- Drugs Capsaicin (Primary) ; Capsaicin
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Centrexion Therapeutics
- 13 Nov 2018 Status changed from recruiting to completed.
- 11 Sep 2018 Planned End Date changed from 1 Sep 2018 to 1 Oct 2018.
- 06 Jul 2018 New trial record